UNIVERSITY OF CALIFORNIA, DAVIS
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1905-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucdavis.edu
Amino Acid Profile and Muscle Protein Synthetic Response to Consuming Meat or Plant-based Alternatives
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Other: Ground beefOther: Ground porkOther: TofuOther: Beyond Meat
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 17
- Registration Number
- NCT04784806
- Locations
- 🇺🇸
CTSC Clinical Research Center, Sacramento, California, United States
Use of CGM in Kidney Transplant Recipients
Not Applicable
Recruiting
- Conditions
- Kidney Transplant; ComplicationsDiabetes Mellitus, Type 2Insulin Dependent Diabetes
- Interventions
- Device: Dexcom G6Device: Dexcom G6 blinded sensor
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 80
- Registration Number
- NCT04783441
- Locations
- 🇺🇸
UC Davis Health, Sacramento, California, United States
Online Network Intervention to Increase HIV Pre-exposure Prophylaxis Intention
Not Applicable
Completed
- Conditions
- Behavior, Health
- Interventions
- Behavioral: Mobile app information-only interventionBehavioral: Mobile app social support network intervention
- First Posted Date
- 2021-02-25
- Last Posted Date
- 2021-10-01
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 50
- Registration Number
- NCT04771312
- Locations
- 🇺🇸
UC Davis, Davis, California, United States
The Influence of Daily Strawberry Intake on Vascular Health in Elderly Men
Not Applicable
Terminated
- Conditions
- Vascular Dilation
- Interventions
- Other: freeze dried strawberry powder
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 4
- Registration Number
- NCT04763499
- Locations
- 🇺🇸
University of California, Davis; Department of Nutrition, Davis, California, United States
Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder
Phase 2
Withdrawn
- Conditions
- Opioid-use Disorder
- Interventions
- First Posted Date
- 2021-02-04
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 24
- Registration Number
- NCT04737603
Arterial Pressure vs. TE Echo dp/dt
Active, not recruiting
- Conditions
- Myocardial Contraction
- Interventions
- Device: Concurrent comparison
- First Posted Date
- 2021-01-27
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 43
- Registration Number
- NCT04726852
- Locations
- 🇺🇸
UC Davis Medical Center, Sacramento, California, United States
Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children
- First Posted Date
- 2021-01-26
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 60
- Registration Number
- NCT04724252
- Locations
- 🇺🇸
UC Davis Medical Center, Sacramento, California, United States
Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes
Not Applicable
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- Behavioral: Remote Patient Monitoring
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 39
- Registration Number
- NCT04696640
- Locations
- 🇺🇸
University of California-Davis, Sacramento, California, United States
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
Early Phase 1
- Conditions
- Lung Cancer, Nonsmall Cell
- Interventions
- Drug: [18F]F-AraG Imaging
- First Posted Date
- 2020-12-22
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 8
- Registration Number
- NCT04678440
- Locations
- 🇺🇸
UC Davis EXPLORER Molecular Imaging Center, Sacramento, California, United States
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
Early Phase 1
Recruiting
- Conditions
- Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic Cancer
- Interventions
- Drug: [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 30
- Registration Number
- NCT04665947
- Locations
- 🇺🇸
University of California Davis, Sacramento, California, United States
© Copyright 2025. All Rights Reserved by MedPath